Protective effect of young green barley leaf (Hordeum vulgare L.) on restraint stress-induced decrease in hippocampal brain-derived neurotrophic factor in mice
Katsunori Yamaura1, Riho Tanaka1, Yuanyuan Bi1, Hideki Fukata2, Nobuo Oishi1, Hiromi Sato1, Chisato Mori3, Koichi Ueno4
1 Department of Geriatric Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
2 Research and Development Division, JPD Co. Ltd., Hyogo, Japan
3 Center for Preventive Medical Science, Chiba University, Chiba, Japan
4 Department of Geriatric Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba; Center for Preventive Medical Science, Chiba University, Chiba, Japan
|Date of Submission||26-Jul-2014|
|Date of Acceptance||18-Sep-2014|
|Date of Web Publication||27-May-2015|
Dr. Katsunori Yamaura
1-8-1, Inohana, Chuo-ku, Chiba 260-8675
Source of Support: In part by Grants-in-Aid for Scientific Research from
the Japan Society for the Promotion of Science, Conflict of Interest: Hideki
Fukata is current employee of JPD Co, Ltd.
| Abstract|| |
Background: Many health experts support the hypothesis that stressful lifestyles are the leading cause of illness, like depression. Therefore, from the standpoint of preventive medicine, it is important to reduce stress. Young green barley leaves are a good natural source of vitamins and minerals, and their juice is widely consumed as a functional food for health reasons in Japan. This study investigated the protective effect of young green barley leaves for stress control. Materials and Methods: ICR outbred mice were exposed to 3-h sessions of restraint stress. Young green barley leaves (400 and 1,000 mg/kg) were administered orally 1 h before the sessions for 5 days. To analyze voluntary behavior, wheel-running activity was monitored during the dark period. Brain-derived neurotrophic factor (BDNF) messenger RNA (mRNA) expression in the whole hippocampus was measured by real-time quantitative polymerase chain reaction. Results: Restraint stress resulted in a significant decrease in voluntary wheel-running behavior, but this decrease was ameliorated by the administration of young green barley leaves. The leaves also enhanced the decreased levels of BDNF mRNA induced by restraint stress; in particular, a significant protective effect was shown in the exon IV variant as compared to vehicle control mice. Conclusion: The findings suggest that young green barley leaves have potent anti-stress properties, as evidenced by preventing decreases in the levels of voluntary wheel-running activity and hippocampal BDNF mRNA in response to restraint stress. Our findings support the possibility that supplementation with young green barley leaves might be beneficial for preventing stress-related psychiatric disorders like depression.
Keywords: Behavioral study, brain-derived neurotrophic factor, functional food, hippocampus, preventive medicine
|How to cite this article:|
Yamaura K, Tanaka R, Bi Y, Fukata H, Oishi N, Sato H, Mori C, Ueno K. Protective effect of young green barley leaf (Hordeum vulgare L.) on restraint stress-induced decrease in hippocampal brain-derived neurotrophic factor in mice. Phcog Mag 2015;11, Suppl S1:86-92
|How to cite this URL:|
Yamaura K, Tanaka R, Bi Y, Fukata H, Oishi N, Sato H, Mori C, Ueno K. Protective effect of young green barley leaf (Hordeum vulgare L.) on restraint stress-induced decrease in hippocampal brain-derived neurotrophic factor in mice. Phcog Mag [serial online] 2015 [cited 2021 Dec 1];11, Suppl S1:86-92. Available from: http://www.phcog.com/text.asp?2015/11/42/86/157702
Katsunori Yamaura, Riho Tanaka
These authors contributed equally to this work.
| Introduction|| |
Many health experts support the hypothesis that a stressful lifestyle is the leading cause of illness, a typical example of which is depression.  Depression is a major global public health issue, both because of its relatively high lifetime prevalence (ranging from 2% to 15%) and because it is associated with substantial disability. 
The findings of many studies indicate that stress management by mindfulness-based stress reduction effectively reduces depressive episodes.  Therefore, from the standpoint of preventive medicine, it is important in the prevention of depression to reduce stress. From the perspective of self-medication specifically, we have been investigating functional foods known to have a positive effect on stress control.
Young green barley leaves are a good natural source of vitamins and minerals, and their juice is widely consumed as a functional food for health reasons in Japan. They are a rich source of the potent antioxidants saponarin and lutonarin  and also exhibit physiological activities, including hypolipidemic,  antidiabetic,  and anti-ulcer  effects, via its anti-oxidative action. In addition, we recently demonstrated that young green barley leaves have anti-depressive effects in mice during the forced swimming test.  Therefore, the aim of the present study was to investigate the protective effect of young green barley leaves for stress control.
It is well-known that glucocorticoid secretion is increased by activation of the hypothalamic-pituitary-adrenal (HPA) axis in response to stress.  Excessive glucocorticoid exposure over long periods impairs the function and integrity of the hippocampus, by causing neurotoxicity. , The progressive process of depression is suggested to be associated with hippocampal atrophy mediated by glucocorticoid neurotoxicity.  Brain-derived neurotrophic factor (BDNF), a small dimeric neuroprotective protein, is reported to play a critical role in the development and maintenance of the central and peripheral nervous systems as well as neuronal survival and proliferation in both animals , and humans.  Serum BDNF concentrations in patients untreated for major depression were found to be significantly lower than those in healthy control subjects. ,, In addition, in animals subjected to forced swimming and chronic restraint stress, BDNF messenger RNA (mRNA) expression levels in the hippocampus were significantly decreased. ,
We recently reported a novel method for evaluating the influences of stress in mice.  Briefly, we evaluated the impact of stress on behavioral responses by suppressing wheel-running activity. We also assessed the influence of stress on neuroprotective agents in the brain by measuring BDNF levels in the hippocampus. Our findings suggested that the behavioral responsivity to restraint stress is associated with the production of hippocampal BDNF, and we showed that a tendency toward a sex difference in the stress response in mice is similar to the sex discrepancy in the prevalence of depression in humans.
In this study, we applied the same method as in our previous work to examine the effects of young green barley leaves as a potential functional food for stress control. First, we evaluated the protective effect of young green barley leaves on the decrease in locomotor activity in response to restraint stress in mice. Second, we measured mRNA expression levels of BDNF in the hippocampus to assess their neuroprotective potency in the increased corticosterone condition with a special focus on the splice variant exon IV.
| Materials and Methods|| |
Six-week-old ICR outbred mice were obtained from Japan SLC Inc. (Hamamatsu, Japan) and housed under controlled light (0700-1900 h) and temperature (24°C ± 1°C) conditions, with food and water available ad libitum. All experiments and procedures were approved by the Chiba University Institutional Animal Care and Use Committee.
Young green barley leaves (Hordeum vulgare L. var. nudum Hook), 20-35 cm in height, were supplied by JPD Co. Ltd. (Hyogo, Japan); the manufacturer collected the specimens in Oita Prefecture, Japan and extracted juice from the leaves to produce a dried powder, in accordance with the company's guide to Good Manufacturing Practice. RIZE ® tablets were obtained from Mitsubishi Tanabe Pharma (Osaka, Japan), corticosterone was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan), and dexamethasone was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). Young green barley leaves were dissolved in distilled water. Clotiazepam was extracted from RIZE ® tablets with methanol and dissolved in distilled water containing 0.5% carboxymethyl cellulose, medium viscosity.
To examine the influence of young green barley leaves on locomotor activity, male mice were subjected to wheel-running seven times every other day from 1730 to 0930 h after 5 days of habituation [Figure 1]a. From day 1 to day 7, young green barley leaves (400 or 1,000 mg/kg), clotiazepam (10 mg/kg), or distilled water (vehicle) were administrated orally at 1000 h. To examine the impact of young green barley leaves on restraint stress, female mice were subjected to wheel-running eight times as mentioned above [Figure 2]a. From day 1 through day 5, mice were treated with each reagent at 1000 h. One hour after the oral administration, all mice except for the nonstressed control animals (Nil) were subjected to enforced restraint stress each day for 3 h from 1100 to 1400 h [Figure 2]a.
|Figure 1: Experimental protocol for measuring wheel-running activity and treatment (a), and the effects of young green barley leaves on voluntary behavior measured by wheel-running activity in male mice (b). Wheel-running activity was evaluated by running distance measured as the total number of wheel rotations in 16 h (1730-0930 h). Results are expressed as mean ± standard error of the mean for n = 7-9 mice. Vehicle: Distilled water; YG400 and YG1000: Young green barley leaf extract at doses of 400 mg/kg and 1,000 mg/kg, respectively; Clo: Clotiazepam at a dose of 10 mg/kg|
Click here to view
|Figure 2: Experimental schedule for restraint stress measuring wheel-running activity and treatment administration (a), and the effects of young green barley leaves on voluntary behavior measured by wheel-running activity in female mice subjected to restraint stress (b). Wheel-running activity was evaluated by running distance measured as the total number of wheel rotations in 16 h (1730-0930 h). Results are expressed as mean ± standard error of the mean for n = 7-9 mice. *P < 0.05 and ***P < 0.001 versus nonstressed (Nil) group on day 3 (Tukey-Kramer test). Vehicle: Distilled water; YG400 and YG1000: Young green barley leaf extract at doses of 400 mg/kg and 1,000 mg/kg, respectively; Clo: Clotiazepam at a dose of 10 mg/kg. The mean wheel-running counts in each experimental group on day-1 were: Nil: 17474.6 ± 1765.0; Vehicle: 17325.0 ± 1200.2; YG400: 16233.5 ± 2204.1; YG1000: 18153.0 ± 1846.3; and Clo: 17154.1 ± 1565.3|
Click here to view
Locomotor activity was evaluated by measuring voluntary wheel-running activity. The mice were housed with free access to a running wheel (wheel diameter 200 mm, cage size 220 mm × 90 mm × 80 mm; TK-48, Toyo-riko Co., Ltd., Tokyo, Japan) for 16 h (1730-0930 h) every other day during the training period (prior to day 0) and the experimental period (after day 0), and food and water were available ad libitum. Voluntary wheel-running activity, defined as the total number of wheel rotations, was recorded at 0930 h and is shown as a percentage compared to day-1.
After six sessions of wheel-running training, female mice excluding those in the Nil group were subjected to restraint. The animals were held in cylindrical plastic tubes (115 mm × 30 mm, with holes to allow access to fresh air) for 3 h (1100-1400 h) [Figure 2]a.
Measurement of serum corticosterone
Blood was collected by retro-orbital bleeding immediately after the final restraint stress test, and centrifuged at 1,000 × g for 20 min. Serum was collected and stored at −80°C prior to analysis. Serum levels of corticosterone were determined by high-performance liquid chromatography (HPLC). Briefly, 20-μl aliquots of standards or samples were transferred to 1.5-ml Eppendorf centrifuge tubes. A 25-μl aliquot of internal standard solution (dexamethasone, 2 μg/ml final concentration) was added to the serum followed by 200 μl ethyl acetate, and briefly mixed on a vortex mixer. The mixture was centrifuged at 5,000 × g for 10 min at 4°C to remove precipitated proteins. An 80-μl aliquot of 0.05 M sodium hydroxide was added to the supernatant and mixed on a vortex mixer. The mixture was centrifuged at 5,000 × g for 5 min at 4°C. The supernatant was then transferred to a 1.5-ml Eppendorf centrifuge tube and evaporated to dryness using a centrifugal concentrator (DNA-mini, Heto, Denmark). Then, 25 μl HPLC mobile phase (35% acetonitrile/65% water) was added and transferred to a 250-μl injection vial. A 5-μl aliquot of the sample or standard solution in the injection vial was subjected to HPLC analysis. A Shiseido Nanospace SI-2 HPLC system (Shiseido Co. Ltd., Tokyo, Japan) was used to measure the concentration of corticosterone. A Unison UK-C-18 column (1.5 mm × 250 mm, 3 μm; Imtakt Corp., Kyoto, Japan) was used at 40°C with a flow rate of 100 μl/min. The mobile phase was 35% acetonitrile/65% water, and corticosterone was detected at a wavelength of 240 nm.
Messenger RNA expression for the glucocorticoid receptor, corticotropin-releasing hormone, and brain-derived neurotrophic factor in brain
Immediately after the final restraint stress test, mice were killed by decapitation and the hippocampus and hypothalamus were removed, according to the method of Hagihara et al.  Hippocampus and hypothalamus samples were homogenized in RNAzol ® RT (Molecular Research Center, Inc., Cincinnati, OH, USA), and centrifuged at 12,000 × g for 5 min at room temperature. The supernatant was collected, and the total RNA was extracted using RNAzol ® RT reagent (Molecular Research Center, Inc.). Total RNA was quantified using an absorbance meter (Smart Spec™3000, BIO-RAD, Hercules, CA, USA). Complementary DNA was prepared from RNA by reverse transcription using a ReverTra Ace ® qPCR RT Master Mix (TOYOBO, Osaka, Japan) with a polymerase chain reaction (PCR) Thermal Cycler Dice ® (Takara Bio Inc., Shiga, Japan). Real-time quantitative PCR was performed using a Step One TM Real-Time PCR system (Applied Biosystems Inc., Carlsbad, CA) with SYBR Premix Ex Taq (Tli RNaseH Plus), ROX plus (Takara Bio Inc.), for mouse BDNF, glucocorticoid receptor (GR), corticotropin-releasing hormone (CRH), and β-actin in accordance with the manufacturer's instructions (Takara Bio Inc.). Results are expressed as the mRNA level relative to β-actin mRNA as an internal control.
All data are presented as mean ± standard error of the mean Statistical significance was analyzed using the Tukey-Kramer test or Dunnett's method for multiple comparisons. Statistical differences in two groups were analyzed using Student's t-test or Aspin-Welch's test after an F-test. Differences at P < 0.05 were considered statistically significant. All statistical analyses were conducted using StatLight software (Yukms Co., Ltd., Tokyo, Japan).
| Results|| |
To examine the influence of young green barley leaves on locomotor activity in mice, we measured wheel-running activity during the dark period. We found no influence of either young green barley leaves or clotiazepam on voluntary behavior in nonstressed mice [Figure 1]b.
Next, we determined the effect of young green barley leaves on mice in response to restraint stress as described above. Restraint stress resulted in a decrease in voluntary wheel-running behavior day by day in vehicle control mice. Moreover, on day 3, wheel-running activity in the vehicle control mice was significantly decreased compared to the nonstressed mice. However, young green barley leaves (400 and 1,000 mg/kg) showed a protective effect on the decrease in wheel-running activity due to restraint stress. The positive control, clotiazepam, further increased wheel-running activity, also indicating an anti-stress effect [Figure 2]b.
Serum corticosterone concentration
The serum glucocorticoid level was measured to investigate the effect of young green barley leaves on the HPA axis. Increased corticosterone levels are used as an index of the stress response in mice, analogous to cortisol in humans. Serum concentration of corticosterone in vehicle control mice increased significantly compared to the nonstressed mice after the final restraint stress test. Treatment with young green barley leaves or clotiazepam did not prevent the increase in serum corticosterone level, compared to vehicle treatment [Figure 3].
|Figure 3: Effects of young green barley leaves on serum corticosterone concentration. Results are expressed as mean ± standard error of the mean for n = 7-9 mice. ***P < 0.001 versus nonstressed (Nil) group (Student's t-test). Vehicle: Distilled water; YG400 and YG1000: Young green barley leaf extract at doses of 400 mg/kg and 1,000 mg/kg, respectively; Clo: Clotiazepam at a dose of 10 mg/kg|
Click here to view
Expression of glucocorticoid receptor messenger RNA in the hippocampus and hypothalamus
Using quantitative PCR, we analyzed the effect of restraint stress in the presence or absence of young green barley leaves on the expression of GR mRNA. The expression of hippocampal GR mRNA in mice immediately after the restraint stress test was significantly decreased compared to the nonstressed mice. Treatment with young green barley leaves or clotiazepam did not alter this decrease in the levels of GR mRNA in the hippocampus [Figure 4]a. In addition, young green barley leaves had no effect on the levels of GR mRNA or CRH mRNA in the hypothalamus [Figure 4]b and c.
|Figure 4: Effects of young green barley leaf extract on glucocorticoid receptor messenger RNA expression in the hippocampus (a) and hypothalamus (b) and corticotropin-releasing hormone expression in the hypothalamus (c) measured by real-time polymerase chain reaction. Results are expressed as mean ± standard error of the mean for n = 7-9 mice. *P < 0.05 versus nonstressed (Nil) group (Student's t-test). Vehicle: Distilled water; YG400 and YG1000: Young green barley leaf extract at doses of 400 mg/kg and 1,000 mg/kg, respectively; Clo: Clotiazepam at a dose of 10 mg/kg|
Click here to view
Expression of brain-derived neurotrophic factor messenger RNA in the hippocampus
To investigate the impact of young green barley leaves on hippocampal BDNF, we analyzed the expression of total BDNF and BDNF exon I and exon IV mRNA in the hippocampus [Figure 5]a-c. BDNF mRNA levels in the vehicle control mice decreased significantly compared to levels in the nonstressed mice. The oral administration of young green barley leaves at the dose of 400 mg/kg weakened this restraint stress-induced decrease; in particular, there was a significant increase in BDNF exon IV as compared to the vehicle control mice. Young green barley leaves at 1,000 mg/kg did not show any effect on BDNF mRNA level. We observed a moderate protective effect of clotiazepam on the decreased levels of total BDNF and BDNF exon I mRNA [Figure 5]a and b.
|Figure 5: Effects of young green barley leaf extract on total brain-derived neurotrophic factor (BDNF) (a), BDNF exon I (b), and BDNF exon IV messenger RNA expression (c) in the hippocampus evaluated by real-time polymerase chain reaction. Results are expressed as mean ± standard error of the mean for n = 7-9 mice. **P < 0.01 versus nonstressed (Nil) group (Aspin Welch's t-test). #P < 0.05 versus vehicle group (Dunnett's test). Vehicle: Distilled water; YG400 and YG1000: Young green barley leaf extract at doses of 400 mg/kg and 1,000 mg/kg, respectively; Clo: Clotiazepam at a dose of 10 mg/kg|
Click here to view
| Discussion|| |
Restraint stress, a severe stressor, is a commonly used method of inducing psychological stress in rodents. , This animal model is useful for understanding the pathophysiology of stress-induced behavioral alterations. In our previous study, we demonstrated that restraint stress significantly decreases locomotor activity in murine wheel-running behavior.  In the present study, we first demonstrated that young green barley leaves enhanced the development of adaptation/resistance of mice in the restraint stress test evaluated by wheel-running behavior. It is known that young green barley leaves do not contain central nervous system stimulants such as caffeine and ephedrine. In our study, young green barley leaves did not have any influence on locomotor activity in untreated mice. Therefore, these leaves might be a functional ingredient with an anti-stressor effect.
Glucocorticoid secretion is increased by activation of the HPA axis in response to stress.  That is, stress stimulates hypothalamic CRH release, which leads to pituitary adrenocorticotropic hormone (ACTH) secretion, resulting in elevated levels of glucocorticoids from the adrenal cortex. The elevation in basal corticosteroids exerts negative feedback regulation on the HPA axis. Excessive stress is associated with insensitivity to the negative feedback regulation of ACTH secretion by glucocorticoids, leading to over-activation of the HPA axis. Therefore, we focused on the GR in the hippocampus and hypothalamus and CRH in the hypothalamus. Excessive release of glucocorticoids impairs the function and integrity of the hippocampus, a brain region with high levels of GR, by causing neurotoxicity. , In the present study, we showed the mRNA levels of GR significantly decreased in the hippocampus following stress loading; however, young green barley leaves showed no impact on these levels. In addition, young green barley leaves had no effect on the levels of GR mRNA or CRH mRNA in the hypothalamus. Therefore, we conclude that young green barley leaves have less effect on the HPA axis.
We also tried to investigate the anti-stressor effect of young green barley leaves using this murine restraint stress model. We first demonstrated the protective effect of young green barley leaves on the restraint stress-induced decrease in locomotor activity. Second, we showed that young green barley leaves alleviated the decreased levels of hippocampal BDNF in restraint-stressed mice. It has been reported that high plasma glucocorticoid levels caused by stress induce hippocampal damage via the GR. Furthermore, exogenous corticosterone, without interfering with the endocrine stress response, induces a reduction in the hippocampal BDNF mRNA level in rats.  The present findings suggest that the decreased level of BDNF mRNA is caused by increased levels of serum corticosterone induced by restraint stress. The mouse BDNF gene has at least eight (I-VIII) noncoding exons and one coding exon (exon IX).  It was reported that a single bout of restraint stress decreased total BDNF (exon IX) and BDNF exon I and IV, but had different effects on BDNF exon I (increase) and IV/IX (decrease), in the rat hippocampus with chronic exposure (10 days).  In the present study, 5 days of restraint stress significantly decreased both exon I and IV levels in the vehicle group. These results suggest that restraint stress in this study can be classified as acute stress. However, the decreased levels of wheel-running activity in the vehicle control mice were much greater on day 3 than on day 1. These findings suggest that chronic stress might be induced by continuing the restraint stress test. Our study was designed from the standpoint of the preventive medicine to gather evidence on functional foods for stress prevention. Therefore, the degree of stress in our model appears to be suitable for investigating the therapeutic effect of young green barley leaves on "sub-health" (health immediately before disease onset).
Brain-derived neurotrophic factor exon IV is the most commonly studied variant, and its expression changes have been associated with behavioral responses following antidepressant treatment in animal models of depression. , Moreover, treatment with antidepressants leads to an up-regulation of BDNF transcript IV levels in the prefrontal cortex of depressive subjects.  The significant ameliorating effect of young green barley leaves on the decreased BDNF exon IV mRNA levels would indicate the possibility of a preventive effect on depression in "sub-healthy" subjects.
In this study, we assessed locomotor activity using running wheel behavior as an indicator of behavioral responses following restraint stress. However, it was reported that the wheel running induced an increase in BDNF concentration in the hippocampus in mice.  First, we demonstrated that young green barley leaves have no effect on voluntary exercise in untreated healthy mice. In addition, young green barley leaves showed a protective effect on the decrease in wheel-running behavior in response to restraint stress. Baj et al. concluded that the increase in BDNF in response to exercise (for 28 consecutive days) was accounted for by the exon VI variant.  In contrast, we demonstrated that young green barley leaves increased the BDNF exon IV variant, and our exercise protocol was 2 alternate days. Based on these findings, the protective effects of young green barley leaves on voluntary exercise against stress could be concluded, as supported by the protective effect on the decrease in BDNF in the hippocampus. Further studies are needed to confirm this link.
Polyphenols, including flavonoids, are well-known antioxidants. Recently, in a critical review of antioxidants, neuroprotective properties in the central nervous system of blueberry polyphenols were reported.  Young green barley leaves also contain the flavonoids saponarin and lutonarin which have potent antioxidant activities. These flavonoids are thought to be responsible for the biological activities of young green barley leaves.  However, further studies are warranted to clarify the active components of young green barley leaves with regard to the anti-stress activity seen in our study. To the best of our knowledge, this is the first study to report the anti-stress properties of young green barley leaves in relation to the protective effect against the hippocampal decrease in BDNF levels in response to restraint stress in mice. Further work is necessary to investigate the molecular signaling pathways that promote the protective effect of these leaves on hippocampal BDNF levels.
Young green barley leaves have potent anti-stress properties, as evidenced by preventing the decrease in levels of voluntary wheel-running activity and hippocampal BDNF mRNA in response to restraint stress. Supplementation with young green barley leaves might, therefore, be beneficial to prevent stress-related psychiatric disorders like depression.
| References|| |
Yulug B, Ozan E, Gönül AS, Kilic E. Brain-derived neurotrophic factor, stress and depression: A minireview. Brain Res Bull 2009;78:267-9.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet 2007;370:851-8.
Niazi AK, Niazi SK. Mindfulness-based stress reduction: A non-pharmacological approach for chronic illnesses. N Am J Med Sci 2011;3:20-3.
Benedet JA, Umeda H, Shibamoto T. Antioxidant activity of flavonoids isolated from young green barley leaves toward biological lipid samples. J Agric Food Chem 2007;55:5499-504.
Yu YM, Wu CH, Tseng YH, Tsai CE, Chang WC. Antioxidative and hypolipidemic effects of barley leaf essence in a rabbit model of atherosclerosis. Jpn J Pharmacol 2002;89:142-8.
Yu YM, Chang WC, Chang CT, Hsieh CL, Tsai CE. Effects of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes. Diabetes Metab 2002;28:107-14.
Ohtake H, Yuasa H, Komura C, Miyauchi T, Hagiwara Y, Kubota K. Studies on the constituents of green juice from young barley leaves. Antiulcer activity of fractions from barley juice. Yakugaku Zasshi 1985;105:1046-51.
Yamaura K, Nakayama N, Shimada M, Bi Y, Fukata H, Ueno K. Antidepressant-like effects of young green barley leaf (Hordeum vulgare
L.) in the mouse forced swimming test. Pharmacognosy Res 2012;4:22-6.
O'Connor TM, O'Halloran DJ, Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: From molecule to melancholia. QJM 2000;93:323-33.
Lee AL, Ogle WO, Sapolsky RM. Stress and depression: Possible links to neuron death in the hippocampus. Bipolar Disord 2002;4:117-28.
Thomas RM, Hotsenpiller G, Peterson DA. Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation. J Neurosci 2007;27:2734-43.
Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996;93:3908-13.
Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999;58:76-87.
Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-94.
Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001;63:71-124.
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109:143-8.
Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005;57:1068-72.
Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005;255:381-6.
Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combination: Impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001;120:87-95.
Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, et al.
Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 2002;321:65-8.
Yamaura K, Bi Y, Ishiwatari M, Oishi N, Fukata H, Ueno K. Sex differences in stress reactivity of hippocampal BDNF in mice are associated with the female preponderance of decreased locomotor activity in response to restraint stress. Zoolog Sci 2013;30:1019-24.
Hagihara H, Toyama K, Yamasaki N, Miyakawa T. Dissection of hippocampal dentate gyrus from adult mouse. J Vis Exp 2009;33:1543.
Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition 2007;23:887-94.
Jaggi AS, Bhatia N, Kumar N, Singh N, Anand P, Dhawan R. A review on animal models for screening potential anti-stress agents. Neurol Sci 2011;32:993-1005.
Hansson AC, Sommer W, Rimondini R, Andbjer B, Strömberg I, Fuxe K. c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J Neurosci 2003;23:6013-22.
Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007;85:525-35.
Nair A, Vadodaria KC, Banerjee SB, Benekareddy M, Dias BG, Duman RS, et al.
Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology 2007;32:1504-19.
Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007;14:268-76.
Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006;9:519-25.
Chen ES, Ernst C, Turecki G. The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. Int J Neuropsychopharmacol 2011;14:427-9.
Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, et al.
Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: Further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 2012;37:1600-11.
Giacalone M, Di Sacco F, Traupe I, Topini R, Forfori F, Giunta F. Antioxidant and neuroprotective properties of blueberry polyphenols: A critical review. Nutr Neurosci 2011;14:119-25.
Kamiyama M, Shibamoto T. Flavonoids with potent antioxidant activity found in young green barley leaves. J Agric Food Chem 2012;60:6260-7.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
|This article has been cited by|
||Highland barley: Chemical composition, bioactive compounds, health effects, and applications
| ||Mohammed Obadi, Jun Sun, Bin Xu |
| ||Food Research International. 2021; 140: 110065 |
|[Pubmed] | [DOI]|
||Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPAR? signaling activation
| ||Daotong Li, Yu Feng, Meiling Tian, Junfu Ji, Xiaosong Hu, Fang Chen |
| ||Microbiome. 2021; 9(1) |
|[Pubmed] | [DOI]|
||Attitudes Toward Psychological Disorders and Alternative Medicine in Saudi Participants
| ||Mohamed H. Alegiry, Nahid H. Hajrah, Nada A. Y Alzahrani, Hossam H. Shawki, Muhammadh Khan, Houda Zrelli, Ahmed Atef, Youngil Kim, Ibrahim A. Alsafari, Leila Arfaoui, Hesham F. Alharby, Abdulrahman S. Hajar, Hesham El-Seedi, Lekh Raj Juneja, Jamal S. M. Sabir, Abdelfatteh El Omri |
| ||Frontiers in Psychiatry. 2021; 12 |
|[Pubmed] | [DOI]|
||Influence of Abiotic Stress Factors on the Antioxidant Properties and Polyphenols Profile Composition of Green Barley (Hordeum vulgare L.)
| ||Przemyslaw Lukasz Kowalczewski, Dominika Radzikowska, Eva Ivanišová, Artur Szwengiel, Miroslava Kacániová, Zuzanna Sawinska |
| ||International Journal of Molecular Sciences. 2020; 21(2): 397 |
|[Pubmed] | [DOI]|
||Variability of Hordeum vulgare L. Cultivars in Yield, Antioxidant Potential, and Cholinesterase Inhibitory Activity
| ||Joanna Kobus-Cisowska, Piotr Szulc, Oskar Szczepaniak, Marcin Dziedzinski, Daria Szymanowska, Krystyna Szymandera-Buszka, Elzbieta Gorynska-Goldmann, Michal Gazdecki, Aleksandra Telichowska, Marta Ligaj |
| ||Sustainability. 2020; 12(5): 1938 |
|[Pubmed] | [DOI]|
||Green Barley as an Ingredient in Pasta: Antioxidant Activity and Sensory Characteristics Evaluation
| ||Eva Ivanišová, Martin Košec, Ján Brindza, Olga Grygorieva, Marián Tokár |
| ||Contemporary Agriculture. 2018; 67(1): 81 |
|[Pubmed] | [DOI]|
||Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex
| ||Valentina Di Liberto,Monica Frinchi,Vincenzo Verdi,Angela Vitale,Fulvio Plescia,Carla Cannizzaro,Maria F. Massenti,Natale Belluardo,Giuseppa Mudň |
| ||Psychopharmacology. 2016; |
|[Pubmed] | [DOI]|